“…However, they can differentiate into monocytic cells that exhibit some endothelial markers and exert pro-angiogenic effects in vivo through a paracrine mechanism [ 41 , 42 ]. These CEPCs, also termed circulating angiogenic cells (CACs) or EC colony-forming units (EC-CFUs) [ 39 , 43 , 44 ], have the ability to secrete a variety of cytokines, growth factors, lipids, and extracellular matrix proteins, providing nutritional and anti-apoptotic support for a variety of other cells with regenerative potential (e.g., ECs, cardiomyocytes, mesenchymal stem cells (MSCs), and neural stem cells (NSCs)) [ 36 , 38 , 45 , 46 ]. This paracrine production includes the secretion of cytokines, growth factors, and chemokines (including VEGF, SDF-1, platelet-derived growth factor (PDGF), and G-CSF) that promote angiogenesis and endothelial proliferation and migration [ 46 , 47 , 48 ].…”